HIVR4P 2016, Partnering for Prevention: Conference Summary and Highlights.
Identifieur interne : 004315 ( Ncbi/Curation ); précédent : 004314; suivant : 004316HIVR4P 2016, Partnering for Prevention: Conference Summary and Highlights.
Auteurs : Barbara L. Shacklett [États-Unis] ; Cynthia A. Derdeyn [Géorgie (pays)] ; Morenike Oluwatoyin Folayan [Nigeria] ; Raphael J. Landovitz [États-Unis] ; Colin Anthony [Afrique du Sud] ; Anna-Janina Behrens [Royaume-Uni] ; Thomas J. Hope [États-Unis] ; Elise Landais [États-Unis] ; Lorna Leal [Espagne] ; Jeanne M. Marrazzo [États-Unis] ; Lynn Morris [Afrique du Sud] ; Nelly Mugo [Kenya] ; Kenneth Ngure [Kenya] ; Veronica Noseda [France] ; Srinika Ranasinghe [États-Unis] ; Damien C. Tully [États-Unis] ; Yegor Voronin [États-Unis] ; Mitchell Warren [États-Unis] ; Constantinos Kurt Wibmer [Afrique du Sud] ; Irene Y. Xie [Canada] ; Gabriella Scarlatti [États-Unis] ; Bargavi Thyagarajan [États-Unis]Source :
- AIDS research and human retroviruses [ 1931-8405 ] ; 2017.
Abstract
HIV Research for Prevention: AIDS Vaccine, Microbicide, and ARV-based Prevention Science (HIVR4P) was built on a growing consensus that effective HIV prevention requires a combination of approaches and that understanding, analyzing, and debating the cross-cutting issues that impact prevention research are all essential to combat the global HIV/AIDS epidemic. To that end, the biennial HIVR4P conference is dedicated to all biomedical HIV prevention research approaches, including HIV vaccines, microbicides, pre-exposure prophylaxis, and treatment as prevention. The HIVR4P 2016 conference was held in Chicago, Illinois (USA), on October 17-21, and included more than 700 scientific presentations and 21 satellite sessions covering the latest and most promising advances across the HIV prevention research field. The theme "Partnering for Prevention" represented the conference's commitment to breaking down silos between research disciplines as well as between researchers, program developers, care providers, advocates, communities, and funders. Delegates spanning 42 countries attended the conference. One-third of those in attendance were early career investigators, which reflects a firm commitment to emerging researchers and ultimately to the goal of developing a sustainable scientific enterprise well into the future. This article presents a concise summary of highlights from the conference. For a more detailed account, one may find full abstracts, daily summaries, and webcasts on the conference website at hivr4p.org.
DOI: 10.1089/AID.2017.0125
PubMed: 28649869
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000E29
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :000E29
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000E29
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :004315
Links to Exploration step
pubmed:28649869Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">HIVR4P 2016, Partnering for Prevention: Conference Summary and Highlights.</title><author><name sortKey="Shacklett, Barbara L" sort="Shacklett, Barbara L" uniqKey="Shacklett B" first="Barbara L" last="Shacklett">Barbara L. Shacklett</name><affiliation wicri:level="2"><nlm:affiliation>1 Department of Medical Microbiology and Immunology and Division of Infectious Diseases, Department of Medicine, School of Medicine, University of California at Davis , Davis, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>1 Department of Medical Microbiology and Immunology and Division of Infectious Diseases, Department of Medicine, School of Medicine, University of California at Davis , Davis</wicri:cityArea></affiliation></author><author><name sortKey="Derdeyn, Cynthia A" sort="Derdeyn, Cynthia A" uniqKey="Derdeyn C" first="Cynthia A" last="Derdeyn">Cynthia A. Derdeyn</name><affiliation wicri:level="1"><nlm:affiliation>2 Department of Pathology and Laboratory Medicine, Emory University , Atlanta, Georgia .</nlm:affiliation><country xml:lang="fr">Géorgie (pays)</country><wicri:regionArea>2 Department of Pathology and Laboratory Medicine, Emory University , Atlanta</wicri:regionArea><wicri:noRegion>Atlanta</wicri:noRegion></affiliation></author><author><name sortKey="Folayan, Morenike Oluwatoyin" sort="Folayan, Morenike Oluwatoyin" uniqKey="Folayan M" first="Morenike Oluwatoyin" last="Folayan">Morenike Oluwatoyin Folayan</name><affiliation wicri:level="1"><nlm:affiliation>3 Department of Child Dental Health, Obafemi Awolowo University , Ile-Ife, New HIV Vaccine and Microbicide Advocacy Society, Lagos, Nigeria .</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>3 Department of Child Dental Health, Obafemi Awolowo University , Ile-Ife, New HIV Vaccine and Microbicide Advocacy Society, Lagos</wicri:regionArea><wicri:noRegion>Lagos</wicri:noRegion></affiliation></author><author><name sortKey="Landovitz, Raphael J" sort="Landovitz, Raphael J" uniqKey="Landovitz R" first="Raphael J" last="Landovitz">Raphael J. Landovitz</name><affiliation wicri:level="2"><nlm:affiliation>4 Division of Infectious Diseases, UCLA Center for Clinical AIDS Research & Education, University of California , Los Angeles, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>4 Division of Infectious Diseases, UCLA Center for Clinical AIDS Research & Education, University of California , Los Angeles</wicri:cityArea></affiliation></author><author><name sortKey="Anthony, Colin" sort="Anthony, Colin" uniqKey="Anthony C" first="Colin" last="Anthony">Colin Anthony</name><affiliation wicri:level="1"><nlm:affiliation>5 Division of Medical Virology, Department of Pathology, Faculty of Health Sciences, Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Cape Town, South Africa .</nlm:affiliation><country xml:lang="fr">Afrique du Sud</country><wicri:regionArea>5 Division of Medical Virology, Department of Pathology, Faculty of Health Sciences, Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Cape Town</wicri:regionArea><wicri:noRegion>Cape Town</wicri:noRegion></affiliation></author><author><name sortKey="Behrens, Anna Janina" sort="Behrens, Anna Janina" uniqKey="Behrens A" first="Anna-Janina" last="Behrens">Anna-Janina Behrens</name><affiliation wicri:level="3"><nlm:affiliation>6 Department of Biochemistry, Oxford Glycobiology Institute, University of Oxford , Oxford, United Kingdom .</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>6 Department of Biochemistry, Oxford Glycobiology Institute, University of Oxford , Oxford</wicri:regionArea><placeName><settlement type="city">Oxford</settlement><region type="country">Angleterre</region><region type="comté" nuts="2">Oxfordshire</region></placeName></affiliation></author><author><name sortKey="Hope, Thomas J" sort="Hope, Thomas J" uniqKey="Hope T" first="Thomas J" last="Hope">Thomas J. Hope</name><affiliation wicri:level="2"><nlm:affiliation>7 Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University , Chicago, Illinois.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Illinois</region></placeName><wicri:cityArea>7 Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University , Chicago</wicri:cityArea></affiliation></author><author><name sortKey="Landais, Elise" sort="Landais, Elise" uniqKey="Landais E" first="Elise" last="Landais">Elise Landais</name><affiliation wicri:level="2"><nlm:affiliation>8 International AIDS Vaccine Initiative, Neutralizing Antibody Center, The Scripps Research Institute , La Jolla, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>8 International AIDS Vaccine Initiative, Neutralizing Antibody Center, The Scripps Research Institute , La Jolla</wicri:cityArea></affiliation></author><author><name sortKey="Leal, Lorna" sort="Leal, Lorna" uniqKey="Leal L" first="Lorna" last="Leal">Lorna Leal</name><affiliation wicri:level="3"><nlm:affiliation>10 Hospital Clínic de Barcelona-IDIBAPS , Barcelona, Spain .</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>10 Hospital Clínic de Barcelona-IDIBAPS , Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author><author><name sortKey="Marrazzo, Jeanne M" sort="Marrazzo, Jeanne M" uniqKey="Marrazzo J" first="Jeanne M" last="Marrazzo">Jeanne M. Marrazzo</name><affiliation wicri:level="2"><nlm:affiliation>11 Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham School of Medicine , Birmingham, Alabama.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Alabama</region></placeName><wicri:cityArea>11 Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham School of Medicine , Birmingham</wicri:cityArea></affiliation></author><author><name sortKey="Morris, Lynn" sort="Morris, Lynn" uniqKey="Morris L" first="Lynn" last="Morris">Lynn Morris</name><affiliation wicri:level="1"><nlm:affiliation>12 National Institute for Communicable Diseases , Johannesburg, South Africa .</nlm:affiliation><country xml:lang="fr">Afrique du Sud</country><wicri:regionArea>12 National Institute for Communicable Diseases , Johannesburg</wicri:regionArea><wicri:noRegion>Johannesburg</wicri:noRegion></affiliation></author><author><name sortKey="Mugo, Nelly" sort="Mugo, Nelly" uniqKey="Mugo N" first="Nelly" last="Mugo">Nelly Mugo</name><affiliation wicri:level="1"><nlm:affiliation>13 Center for Clinical Research, Kenya Medical Research Institute , Nairobi, Kenya .</nlm:affiliation><country xml:lang="fr">Kenya</country><wicri:regionArea>13 Center for Clinical Research, Kenya Medical Research Institute , Nairobi</wicri:regionArea><wicri:noRegion>Nairobi</wicri:noRegion></affiliation></author><author><name sortKey="Ngure, Kenneth" sort="Ngure, Kenneth" uniqKey="Ngure K" first="Kenneth" last="Ngure">Kenneth Ngure</name><affiliation wicri:level="1"><nlm:affiliation>14 Department of Public and Community Health, Jomo Kenyatta University of Agriculture and Technology , Nairobi, Kenya .</nlm:affiliation><country xml:lang="fr">Kenya</country><wicri:regionArea>14 Department of Public and Community Health, Jomo Kenyatta University of Agriculture and Technology , Nairobi</wicri:regionArea><wicri:noRegion>Nairobi</wicri:noRegion></affiliation></author><author><name sortKey="Noseda, Veronica" sort="Noseda, Veronica" uniqKey="Noseda V" first="Veronica" last="Noseda">Veronica Noseda</name><affiliation wicri:level="3"><nlm:affiliation>15 Planned Parenthood France/Le Planning Familial , Paris, France .</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>15 Planned Parenthood France/Le Planning Familial , Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Ranasinghe, Srinika" sort="Ranasinghe, Srinika" uniqKey="Ranasinghe S" first="Srinika" last="Ranasinghe">Srinika Ranasinghe</name><affiliation wicri:level="2"><nlm:affiliation>16 Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University , Cambridge, Massachusetts.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea>16 Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University , Cambridge</wicri:cityArea></affiliation></author><author><name sortKey="Tully, Damien C" sort="Tully, Damien C" uniqKey="Tully D" first="Damien C" last="Tully">Damien C. Tully</name><affiliation wicri:level="2"><nlm:affiliation>16 Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University , Cambridge, Massachusetts.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea>16 Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University , Cambridge</wicri:cityArea></affiliation></author><author><name sortKey="Voronin, Yegor" sort="Voronin, Yegor" uniqKey="Voronin Y" first="Yegor" last="Voronin">Yegor Voronin</name><affiliation wicri:level="2"><nlm:affiliation>17 Global HIV Vaccine Enterprise , New York, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>17 Global HIV Vaccine Enterprise , New York</wicri:cityArea></affiliation></author><author><name sortKey="Warren, Mitchell" sort="Warren, Mitchell" uniqKey="Warren M" first="Mitchell" last="Warren">Mitchell Warren</name><affiliation wicri:level="2"><nlm:affiliation>18 AVAC , New York, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>18 AVAC , New York</wicri:cityArea></affiliation></author><author><name sortKey="Wibmer, Constantinos Kurt" sort="Wibmer, Constantinos Kurt" uniqKey="Wibmer C" first="Constantinos Kurt" last="Wibmer">Constantinos Kurt Wibmer</name><affiliation wicri:level="1"><nlm:affiliation>19 Faculty of Health Sciences, Centre for HIV and STIs, National Institute for Communicable Diseases (NICD), of the National Health Laboratory Service (NHLS), University of the Witwatersrand , Johannesburg, South Africa .</nlm:affiliation><country xml:lang="fr">Afrique du Sud</country><wicri:regionArea>19 Faculty of Health Sciences, Centre for HIV and STIs, National Institute for Communicable Diseases (NICD), of the National Health Laboratory Service (NHLS), University of the Witwatersrand , Johannesburg</wicri:regionArea><wicri:noRegion>Johannesburg</wicri:noRegion></affiliation></author><author><name sortKey="Xie, Irene Y" sort="Xie, Irene Y" uniqKey="Xie I" first="Irene Y" last="Xie">Irene Y. Xie</name><affiliation wicri:level="1"><nlm:affiliation>20 National HIV and Retrovirology Labs, Department of Medical Microbiology and Infectious Diseases, JC Wilt Center for Infectious Diseases, Public Health Agency of Canada, University of Manitoba , Winnipeg, Canada .</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>20 National HIV and Retrovirology Labs, Department of Medical Microbiology and Infectious Diseases, JC Wilt Center for Infectious Diseases, Public Health Agency of Canada, University of Manitoba , Winnipeg</wicri:regionArea><wicri:noRegion>Winnipeg</wicri:noRegion></affiliation></author><author><name sortKey="Scarlatti, Gabriella" sort="Scarlatti, Gabriella" uniqKey="Scarlatti G" first="Gabriella" last="Scarlatti">Gabriella Scarlatti</name><affiliation wicri:level="2"><nlm:affiliation>17 Global HIV Vaccine Enterprise , New York, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>17 Global HIV Vaccine Enterprise , New York</wicri:cityArea></affiliation></author><author><name sortKey="Thyagarajan, Bargavi" sort="Thyagarajan, Bargavi" uniqKey="Thyagarajan B" first="Bargavi" last="Thyagarajan">Bargavi Thyagarajan</name><affiliation wicri:level="2"><nlm:affiliation>17 Global HIV Vaccine Enterprise , New York, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>17 Global HIV Vaccine Enterprise , New York</wicri:cityArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28649869</idno><idno type="pmid">28649869</idno><idno type="doi">10.1089/AID.2017.0125</idno><idno type="wicri:Area/PubMed/Corpus">000E29</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000E29</idno><idno type="wicri:Area/PubMed/Curation">000E29</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000E29</idno><idno type="wicri:Area/PubMed/Checkpoint">000E29</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000E29</idno><idno type="wicri:Area/Ncbi/Merge">004315</idno><idno type="wicri:Area/Ncbi/Curation">004315</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">HIVR4P 2016, Partnering for Prevention: Conference Summary and Highlights.</title><author><name sortKey="Shacklett, Barbara L" sort="Shacklett, Barbara L" uniqKey="Shacklett B" first="Barbara L" last="Shacklett">Barbara L. Shacklett</name><affiliation wicri:level="2"><nlm:affiliation>1 Department of Medical Microbiology and Immunology and Division of Infectious Diseases, Department of Medicine, School of Medicine, University of California at Davis , Davis, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>1 Department of Medical Microbiology and Immunology and Division of Infectious Diseases, Department of Medicine, School of Medicine, University of California at Davis , Davis</wicri:cityArea></affiliation></author><author><name sortKey="Derdeyn, Cynthia A" sort="Derdeyn, Cynthia A" uniqKey="Derdeyn C" first="Cynthia A" last="Derdeyn">Cynthia A. Derdeyn</name><affiliation wicri:level="1"><nlm:affiliation>2 Department of Pathology and Laboratory Medicine, Emory University , Atlanta, Georgia .</nlm:affiliation><country xml:lang="fr">Géorgie (pays)</country><wicri:regionArea>2 Department of Pathology and Laboratory Medicine, Emory University , Atlanta</wicri:regionArea><wicri:noRegion>Atlanta</wicri:noRegion></affiliation></author><author><name sortKey="Folayan, Morenike Oluwatoyin" sort="Folayan, Morenike Oluwatoyin" uniqKey="Folayan M" first="Morenike Oluwatoyin" last="Folayan">Morenike Oluwatoyin Folayan</name><affiliation wicri:level="1"><nlm:affiliation>3 Department of Child Dental Health, Obafemi Awolowo University , Ile-Ife, New HIV Vaccine and Microbicide Advocacy Society, Lagos, Nigeria .</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>3 Department of Child Dental Health, Obafemi Awolowo University , Ile-Ife, New HIV Vaccine and Microbicide Advocacy Society, Lagos</wicri:regionArea><wicri:noRegion>Lagos</wicri:noRegion></affiliation></author><author><name sortKey="Landovitz, Raphael J" sort="Landovitz, Raphael J" uniqKey="Landovitz R" first="Raphael J" last="Landovitz">Raphael J. Landovitz</name><affiliation wicri:level="2"><nlm:affiliation>4 Division of Infectious Diseases, UCLA Center for Clinical AIDS Research & Education, University of California , Los Angeles, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>4 Division of Infectious Diseases, UCLA Center for Clinical AIDS Research & Education, University of California , Los Angeles</wicri:cityArea></affiliation></author><author><name sortKey="Anthony, Colin" sort="Anthony, Colin" uniqKey="Anthony C" first="Colin" last="Anthony">Colin Anthony</name><affiliation wicri:level="1"><nlm:affiliation>5 Division of Medical Virology, Department of Pathology, Faculty of Health Sciences, Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Cape Town, South Africa .</nlm:affiliation><country xml:lang="fr">Afrique du Sud</country><wicri:regionArea>5 Division of Medical Virology, Department of Pathology, Faculty of Health Sciences, Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Cape Town</wicri:regionArea><wicri:noRegion>Cape Town</wicri:noRegion></affiliation></author><author><name sortKey="Behrens, Anna Janina" sort="Behrens, Anna Janina" uniqKey="Behrens A" first="Anna-Janina" last="Behrens">Anna-Janina Behrens</name><affiliation wicri:level="3"><nlm:affiliation>6 Department of Biochemistry, Oxford Glycobiology Institute, University of Oxford , Oxford, United Kingdom .</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>6 Department of Biochemistry, Oxford Glycobiology Institute, University of Oxford , Oxford</wicri:regionArea><placeName><settlement type="city">Oxford</settlement><region type="country">Angleterre</region><region type="comté" nuts="2">Oxfordshire</region></placeName></affiliation></author><author><name sortKey="Hope, Thomas J" sort="Hope, Thomas J" uniqKey="Hope T" first="Thomas J" last="Hope">Thomas J. Hope</name><affiliation wicri:level="2"><nlm:affiliation>7 Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University , Chicago, Illinois.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Illinois</region></placeName><wicri:cityArea>7 Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University , Chicago</wicri:cityArea></affiliation></author><author><name sortKey="Landais, Elise" sort="Landais, Elise" uniqKey="Landais E" first="Elise" last="Landais">Elise Landais</name><affiliation wicri:level="2"><nlm:affiliation>8 International AIDS Vaccine Initiative, Neutralizing Antibody Center, The Scripps Research Institute , La Jolla, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>8 International AIDS Vaccine Initiative, Neutralizing Antibody Center, The Scripps Research Institute , La Jolla</wicri:cityArea></affiliation></author><author><name sortKey="Leal, Lorna" sort="Leal, Lorna" uniqKey="Leal L" first="Lorna" last="Leal">Lorna Leal</name><affiliation wicri:level="3"><nlm:affiliation>10 Hospital Clínic de Barcelona-IDIBAPS , Barcelona, Spain .</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>10 Hospital Clínic de Barcelona-IDIBAPS , Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author><author><name sortKey="Marrazzo, Jeanne M" sort="Marrazzo, Jeanne M" uniqKey="Marrazzo J" first="Jeanne M" last="Marrazzo">Jeanne M. Marrazzo</name><affiliation wicri:level="2"><nlm:affiliation>11 Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham School of Medicine , Birmingham, Alabama.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Alabama</region></placeName><wicri:cityArea>11 Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham School of Medicine , Birmingham</wicri:cityArea></affiliation></author><author><name sortKey="Morris, Lynn" sort="Morris, Lynn" uniqKey="Morris L" first="Lynn" last="Morris">Lynn Morris</name><affiliation wicri:level="1"><nlm:affiliation>12 National Institute for Communicable Diseases , Johannesburg, South Africa .</nlm:affiliation><country xml:lang="fr">Afrique du Sud</country><wicri:regionArea>12 National Institute for Communicable Diseases , Johannesburg</wicri:regionArea><wicri:noRegion>Johannesburg</wicri:noRegion></affiliation></author><author><name sortKey="Mugo, Nelly" sort="Mugo, Nelly" uniqKey="Mugo N" first="Nelly" last="Mugo">Nelly Mugo</name><affiliation wicri:level="1"><nlm:affiliation>13 Center for Clinical Research, Kenya Medical Research Institute , Nairobi, Kenya .</nlm:affiliation><country xml:lang="fr">Kenya</country><wicri:regionArea>13 Center for Clinical Research, Kenya Medical Research Institute , Nairobi</wicri:regionArea><wicri:noRegion>Nairobi</wicri:noRegion></affiliation></author><author><name sortKey="Ngure, Kenneth" sort="Ngure, Kenneth" uniqKey="Ngure K" first="Kenneth" last="Ngure">Kenneth Ngure</name><affiliation wicri:level="1"><nlm:affiliation>14 Department of Public and Community Health, Jomo Kenyatta University of Agriculture and Technology , Nairobi, Kenya .</nlm:affiliation><country xml:lang="fr">Kenya</country><wicri:regionArea>14 Department of Public and Community Health, Jomo Kenyatta University of Agriculture and Technology , Nairobi</wicri:regionArea><wicri:noRegion>Nairobi</wicri:noRegion></affiliation></author><author><name sortKey="Noseda, Veronica" sort="Noseda, Veronica" uniqKey="Noseda V" first="Veronica" last="Noseda">Veronica Noseda</name><affiliation wicri:level="3"><nlm:affiliation>15 Planned Parenthood France/Le Planning Familial , Paris, France .</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>15 Planned Parenthood France/Le Planning Familial , Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Ranasinghe, Srinika" sort="Ranasinghe, Srinika" uniqKey="Ranasinghe S" first="Srinika" last="Ranasinghe">Srinika Ranasinghe</name><affiliation wicri:level="2"><nlm:affiliation>16 Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University , Cambridge, Massachusetts.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea>16 Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University , Cambridge</wicri:cityArea></affiliation></author><author><name sortKey="Tully, Damien C" sort="Tully, Damien C" uniqKey="Tully D" first="Damien C" last="Tully">Damien C. Tully</name><affiliation wicri:level="2"><nlm:affiliation>16 Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University , Cambridge, Massachusetts.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea>16 Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University , Cambridge</wicri:cityArea></affiliation></author><author><name sortKey="Voronin, Yegor" sort="Voronin, Yegor" uniqKey="Voronin Y" first="Yegor" last="Voronin">Yegor Voronin</name><affiliation wicri:level="2"><nlm:affiliation>17 Global HIV Vaccine Enterprise , New York, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>17 Global HIV Vaccine Enterprise , New York</wicri:cityArea></affiliation></author><author><name sortKey="Warren, Mitchell" sort="Warren, Mitchell" uniqKey="Warren M" first="Mitchell" last="Warren">Mitchell Warren</name><affiliation wicri:level="2"><nlm:affiliation>18 AVAC , New York, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>18 AVAC , New York</wicri:cityArea></affiliation></author><author><name sortKey="Wibmer, Constantinos Kurt" sort="Wibmer, Constantinos Kurt" uniqKey="Wibmer C" first="Constantinos Kurt" last="Wibmer">Constantinos Kurt Wibmer</name><affiliation wicri:level="1"><nlm:affiliation>19 Faculty of Health Sciences, Centre for HIV and STIs, National Institute for Communicable Diseases (NICD), of the National Health Laboratory Service (NHLS), University of the Witwatersrand , Johannesburg, South Africa .</nlm:affiliation><country xml:lang="fr">Afrique du Sud</country><wicri:regionArea>19 Faculty of Health Sciences, Centre for HIV and STIs, National Institute for Communicable Diseases (NICD), of the National Health Laboratory Service (NHLS), University of the Witwatersrand , Johannesburg</wicri:regionArea><wicri:noRegion>Johannesburg</wicri:noRegion></affiliation></author><author><name sortKey="Xie, Irene Y" sort="Xie, Irene Y" uniqKey="Xie I" first="Irene Y" last="Xie">Irene Y. Xie</name><affiliation wicri:level="1"><nlm:affiliation>20 National HIV and Retrovirology Labs, Department of Medical Microbiology and Infectious Diseases, JC Wilt Center for Infectious Diseases, Public Health Agency of Canada, University of Manitoba , Winnipeg, Canada .</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>20 National HIV and Retrovirology Labs, Department of Medical Microbiology and Infectious Diseases, JC Wilt Center for Infectious Diseases, Public Health Agency of Canada, University of Manitoba , Winnipeg</wicri:regionArea><wicri:noRegion>Winnipeg</wicri:noRegion></affiliation></author><author><name sortKey="Scarlatti, Gabriella" sort="Scarlatti, Gabriella" uniqKey="Scarlatti G" first="Gabriella" last="Scarlatti">Gabriella Scarlatti</name><affiliation wicri:level="2"><nlm:affiliation>17 Global HIV Vaccine Enterprise , New York, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>17 Global HIV Vaccine Enterprise , New York</wicri:cityArea></affiliation></author><author><name sortKey="Thyagarajan, Bargavi" sort="Thyagarajan, Bargavi" uniqKey="Thyagarajan B" first="Bargavi" last="Thyagarajan">Bargavi Thyagarajan</name><affiliation wicri:level="2"><nlm:affiliation>17 Global HIV Vaccine Enterprise , New York, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>17 Global HIV Vaccine Enterprise , New York</wicri:cityArea></affiliation></author></analytic><series><title level="j">AIDS research and human retroviruses</title><idno type="eISSN">1931-8405</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">HIV Research for Prevention: AIDS Vaccine, Microbicide, and ARV-based Prevention Science (HIVR4P) was built on a growing consensus that effective HIV prevention requires a combination of approaches and that understanding, analyzing, and debating the cross-cutting issues that impact prevention research are all essential to combat the global HIV/AIDS epidemic. To that end, the biennial HIVR4P conference is dedicated to all biomedical HIV prevention research approaches, including HIV vaccines, microbicides, pre-exposure prophylaxis, and treatment as prevention. The HIVR4P 2016 conference was held in Chicago, Illinois (USA), on October 17-21, and included more than 700 scientific presentations and 21 satellite sessions covering the latest and most promising advances across the HIV prevention research field. The theme "Partnering for Prevention" represented the conference's commitment to breaking down silos between research disciplines as well as between researchers, program developers, care providers, advocates, communities, and funders. Delegates spanning 42 countries attended the conference. One-third of those in attendance were early career investigators, which reflects a firm commitment to emerging researchers and ultimately to the goal of developing a sustainable scientific enterprise well into the future. This article presents a concise summary of highlights from the conference. For a more detailed account, one may find full abstracts, daily summaries, and webcasts on the conference website at hivr4p.org.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004315 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 004315 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaSubSaharaV1
|flux= Ncbi
|étape= Curation
|type= RBID
|clé= pubmed:28649869
|texte= HIVR4P 2016, Partnering for Prevention: Conference Summary and Highlights.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:28649869" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \
| NlmPubMed2Wicri -a SidaSubSaharaV1
| This area was generated with Dilib version V0.6.32. |  |